Endoscopy 2010; 42(7): 536-540
DOI: 10.1055/s-0029-1244123
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Esophageal stents for the relief of malignant dysphagia due to extrinsic compression

N.  C.  M.  van Heel1 , J.  Haringsma1 , M.  C.  W.  Spaander1 , M.  J.  Bruno1 , E.  J.  Kuipers1 , 2
  • 1Department of Gastroenterology and Hepatology, Erasmus MC – University Medical Center Rotterdam, The Netherlands
  • 2Department of Internal Medicine, Erasmus MC – University Medical Center Rotterdam, The Netherlands
Further Information

Publication History

submitted 2 November 2009

accepted after revision 15 March 2010

Publication Date:
29 April 2010 (online)

Background and study aims: In patients with primary esophageal cancer, luminal patency can be restored by placement of a self-expandable metal stent (SEMS). The use of SEMS in patients with dysphagia caused by malignant extrinsic compression has largely been unreported. In this study we evaluated the efficacy of SEMS in a large cohort of patients with malignant extrinsic compression.

Patients and methods: This was a prospective single-center study. Between 1995 and 2009, 50 consecutive patients with malignant extrinsic compression who had undergone SEMS placement were included (mean age 64 years; 37-males). In the majority of patients, extrinsic esophageal compression was caused by obstructive pulmonary cancer (n = 23) and by mediastinal metastasis after esophagectomy for esophageal cancer (n = 16).

Results: Stent placement was technically successful in all patients. Severe complications occurred in 5 / 50 patients (10 %) including perforation during dilation prior to stent insertion (n = 2) and hemorrhage (n = 3). Two patients (4 %) died from bleeding. Mild complications were seen in 9 / 50 patients (18 %). Recurrent dysphagia occurred in eight patients (16 %) and was successfully managed by subsequent endoscopic intervention. Median survival after stent placement was 44 days (range 5 days – 2 years). The median stent patency of 46 days in this series exceeded median patient survival.

Conclusions: Insertion of an SEMS is an effective palliative treatment for patients with dysphagia due to malignant extrinsic compression. In spite of the short survival, some patients present with recurrent dysphagia, which can be managed effectively by endoscopic re-intervention.

References

  • 1 Keller R, Flieger D, Fischbach W, Christl S U. Self-expanding metal stents for malignant esophagogastric obstruction: experience with a new design covered nitinol stent.  J Gastrointest Liver Dis. 2007;  16 239-243
  • 2 Sobel J M, Lai R, Mallery S. et al . The utility of EUS-guided FNA in the diagnosis of metastatic breast cancer to the esophagus and the mediastinum.  Gastrointest Endosc. 2005;  61 416-420
  • 3 Homs M Y, Steyerberg E W, Eijkenboom W M. et al . Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.  Lancet. 2004;  364 1497-1504
  • 4 Wilkes E A, Jackson L M, Cole A T. et al . Insertion of expandable metallic stents in esophageal cancer without fluoroscopy is safe and effective: a 5-year experience.  Gastrointest Endosc. 2007;  65 923-929
  • 5 Gupta N K, Boylan C E, Razzaq R. et al . Self-expanding oesophageal metal stents for the palliation of dysphagia due to extrinsic compression.  Eur Radiol. 1999;  9 1893-1897
  • 6 Homs M Y, Kuipers E J, Siersema P D. Palliative therapy.  J Surg Oncol. 2005;  92 246-256
  • 7 Verschuur E M, Kuipers E J, Siersema P D. Esophageal stents for malignant strictures close to the upper esophageal sphincter.  Gastrointest Endosc. 2007;  66 1082-1090
  • 8 Sabharwal T, Hamady M S, Chui S. et al . A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.  Gut. 2003;  52 922-926
  • 9 Verschuur E M, Repici A, Kuipers E J. et al . New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial.  Am J Gastroenterol. 2008;  103 304-312
  • 10 Knyrim K, Wagner H J, Bethge N. et al . A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer.  New Engl J Med. 1993;  329 1302-1307
  • 11 Litle V R, Luketich J D, Christie N A. et al . Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients.  Ann Thorac Surg. 2003;  76 1687-1692; discussion 1692 – 1683
  • 12 White R E, Parker R K, Fitzwater J W. et al . Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement.  Lancet Oncology. 2009;  10 240-246
  • 13 Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients.  Gastrointest Endosc. 1998;  48 172-179
  • 14 O"Donnell C A, Fullarton G M, Watt E. et al . Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer.  Br J Surg. 2002;  89 985-992
  • 15 Bethge N, Sommer A, Vakil N. Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents.  Am J Gastroenterol. 1998;  93 1829-1832
  • 16 Vakil N, Morris A I, Marcon N. et al . A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction.  Am J Gastroenterol. 2001;  96 1791-1796
  • 17 Laasch H U, Marriott A, Wilbraham L. et al . Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux.  Radiology. 2002;  225 359-365
  • 18 Neyaz Z, Srivastava D N, Thulkar S. et al . Radiological evaluation of covered self-expandable metallic stents used for palliation in patients with malignant esophageal strictures.  Acta Radiol. 2007;  48 156-164
  • 19 Verschuur E M, Repici A, Kuipers E J. et al . New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial.  Am J Gastroenterol. 2008;  103 304-312
  • 20 Kim E S, Jeon S W, Park S Y. et al . Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia.  J Gastroenterol Hepatol. 2009;  24 2-4
  • 21 Bartelsman J F, Bruno M J, Jensema A J. et al . Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients.  Gastrointest Endosc. 2000;  51 134-138
  • 22 Fischer A, Thomusch O, Benz S. et al . Nonoperative treatment of 15 benign esophageal perforations with self-expandable covered metal stents.  Ann Thorac Surg. 2006;  81 467-472
  • 23 Wang M Q, Sze D Y, Wang Z P. et al . Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas.  J Vasc Interv Radiol. 2001;  12 465-474
  • 24 Ludwig D, Dehne A, Burmester E. et al . Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy.  Int J Oncol. 1998;  13 583-588
  • 25 Homs M Y, Hansen B E, van Blankenstein M. et al . Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma.  Eur J Gastroenterol Hepatol. 2004;  16 163-170
  • 26 Nishimura Y, Nagata K, Katano S. et al . Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases.  Int J Radiat Oncol Biol Phys. 2003;  56 1327-1332
  • 27 Lecleire S, Di Fiore F, Ben-Soussan E. et al . Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer.  Aliment Pharmacol Ther. 2006;  23 1693-1702
  • 28 Homs M Y, Steyerberg E W, Kuipers E J. et al . Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma.  Endoscopy. 2004;  36 880-886
  • 29 Christie N A, Buenaventura P O, Fernando H C. et al . Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up.  Ann Thorac Surg. 2001;  71 1797-1801; discussion 1801 – 1792
  • 30 Metcalfe M J, Steger A C, Leslie A. Benign complications of expandable metal stents used in the palliation of oesophageal carcinoma: two case reports.  Br J Radiol. 2004;  77 245-247
  • 31 Grundy A, Glees J P. Aorto-oesophageal fistula: a complication of oesophageal stenting.  Br J Radiol. 1997;  70 846-849
  • 32 Tan B S, Mason R C, Adam A. Minimally invasive therapy for advanced oesophageal malignancy.  Clin Radiol. 1996;  51 828-836
  • 33 Dua K S, Vleggaar F P, Santharam R, Siersema P D. Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study.  Am J Gastroenterol. 2008;  103 2988-2994
  • 34 Binkert C A, Petersen B D. Two fatal complications after parallel tracheal-esophageal stenting.  Cardiovasc Intervent Radiol. 2002;  25 144-147

N. C. M. van HeelMD 

Department of Gastroenterology and Hepatology
Erasmus MC – University Medical Center Rotterdam

Postbox 2040
3000 CA Rotterdam
The Netherlands

Email: n.vanheel@erasmusmc.nl

    >